# China NMPA Drug Inspection - Suzhou Chunhuitang Pharmaceutical Co., Ltd. - Fennel

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/suzhou-chunhuitang-pharmaceutical-co-ltd/b20d50da-eda9-41fc-98c6-61a807ff4b2c/
Source feed: China

> China NMPA drug inspection for Suzhou Chunhuitang Pharmaceutical Co., Ltd. published April 09, 2018. Drug: Fennel. The Shanghai Municipal Food and Drug Administration (SMFDA) issued an announcement on April 9, 2018, detailing the resul

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Shanghai Municipal Food and Drug Administration's Third Announcement on Drug Supervision and Sampling Quality in 2018 (April 9, 2018)
- Company Name: Suzhou Chunhuitang Pharmaceutical Co., Ltd.
- Publication Date: 2018-04-09
- Drug Name: Fennel
- Inspection Finding: Content determination
- Action Taken: The authorities will investigate and punish the violations according to law, requiring the suspension of sales and use of substandard products, recall of substandard products, and urging enterprises to investigate the causes, implement corrective measures, and strengthen follow-up inspections and daily supervision.
- Summary: The Shanghai Municipal Food and Drug Administration (SMFDA) issued an announcement on April 9, 2018, detailing the results of its 2018 drug and pharmaceutical packaging material supervision and sampling inspections. These inspections aimed to ensure the quality and safety of products on the market, regulating drug and packaging material manufacturers, distributors, and users.Several companies were identified for non-compliant products. Suzhou Boyuan Pharmaceutical Co., Ltd. was cited for deficiencies in Polygonum multiflorum (He Shou Wu) and Glehnia littoralis (Bei Sha Shen) processed slices, specifically related to "Content Determination" and "Sulfur Dioxide Residue," referencing the 2015 Chinese Pharmacopoeia. Shanghai First People's Hospital's Clodisongol Cream exhibited "Content Difference" against internal standards. Suzhou Chunhuitang Pharmaceutical Co., Ltd.'s Fennel Seeds also failed "Content Determination." Additionally, Shanghai Huayi Group Huayuan Chemical Co., Ltd.'s Solid Pharmaceutical Polyethylene Bottled Silica Gel Desiccant was non-compliant regarding its "Moisture Absorption Rate."The SMFDA has mandated that involved companies immediately implement risk control measures, including suspending sales, halting use, and initiating recalls for affected products. Regulatory departments are tasked with investigating and penalizing illegal activities. Furthermore, companies are required to thoroughly investigate the root causes of these issues, develop, and execute corrective actions to eliminate potential risks, with ongoing daily supervision from local market supervision bureaus.

Company: https://www.globalkeysolutions.net/companies/suzhou-chunhuitang-pharmaceutical-co-ltd/5b4bff62-8d47-4f69-b289-c097b6c34d64/